A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Individuals

BACKGROUND: In HIV infection, lymphoid tissue is disrupted by fibrosis. Angiotensin converting enzyme inhibitors have anti-fibrotic properties. We completed a pilot study to assess whether the addition of lisinopril to antiretroviral therapy (ART) reverses fibrosis of gut tissue, and whether this le...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pathog Immun
Autors principals: Cockerham, Leslie R., Yukl, Steven A., Harvill, Kara, Somsouk, Ma, Joshi, Sunil K., Sinclair, Elizabeth, Liegler, Teri, Hoh, Rebecca, Lyons, Sophie, Hunt, Peter W., Rupert, Adam, Sereti, Irini, Morcock, David R., Rhodes, Ajantha, Emson, Claire, Hellerstein, Marc K., Estes, Jacob D., Lewin, Sharon, Deeks, Steven G., Hatano, Hiroyu
Format: Artigo
Idioma:Inglês
Publicat: Pathogens and Immunity 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5604865/
https://ncbi.nlm.nih.gov/pubmed/28936485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20411/pai.v2i3.207
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars